INOVIO PHARMACEUTICALS, INC. (INO) Total liabilities 2016–2025
INOVIO PHARMACEUTICALS, INC. (INO) total liabilities at each fiscal year-end, per SEC filings.
$50.2MFY2025 · since FY2016: $50.3M → $50.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $50.2M | +12.4% |
| FY2024 | $44.7M | -16.6% |
| FY2023 | $53.6M | -57.5% |
| FY2022 | $126.2M | +31.1% |
| FY2021 | $96.3M | +22.4% |
| FY2020 | $78.6M | -43.2% |
| FY2019 | $138.5M | +214.3% |
| FY2018 | $44.1M | -1.5% |
| FY2017 | $44.8M | -11.1% |
| FY2016 | $50.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice